Cited by 555Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesInfectious Encephalopathies and Encephalitis

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

Open access

Heneka, Michael T., Golenbock, Douglas, Latz, Eicke, Morgan, Dave, Brown, Robert·2020·Alzheimer's Research & Therapy

DOI 10.1186/s13195-020-00640-3PMC PMC7271826

Open this paper in CoChat — free account Open PDF

Abstract

Increasing evidence suggests that infection with Sars-CoV-2 causes neurological deficits in a substantial proportion of affected patients. While these symptoms arise acutely during the course of infection, less is known about the possible long-term consequences for the brain. Severely affected COVID-19 cases experience high levels of proinflammatory cytokines and acute respiratory dysfunction and often require assisted ventilation. All these factors have been suggested to cause cognitive decline. Pathogenetically, this may result from direct negative effects of the immune reaction, acceleration or aggravation of pre-existing cognitive deficits, or de novo induction of a neurodegenerative disease. This article summarizes the current understanding of neurological symptoms of COVID-19 and hypothesizes that affected patients may be at higher risk of developing cognitive decline after overcoming the primary COVID-19 infection. A structured prospective evaluation should analyze the likelihood, time course, and severity of cognitive impairment following the COVID-19 pandemic.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s13195-020-00640-3

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898
Self-citation
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
Lechien, J. R., Chiesa-Estomba, C. M., De Siati, D. R., Horoi, M., Le Bon, S. D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-05965-1 · Cited by 2,668 · cited 1×
“Importantly, in about 11% of patients, anosmia occurred prior to any other clinical symptoms [3].”
Background
Long-term cognitive impairment and functional disability among survivors of severe sepsis.
Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., Leacy, R. A. D., Shigematsu, T., Ladner, T. R., Yaeger, K., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,114

Show all 27 references

Sorted by citations

Items 501–549 of 549

Complicações neurológicas em pacientes pós-COVID-19
Sousa, G. H. M., & Melo, R. S. B. (2024) · Fisioterapia em Movimento · doi:10.1590/fm.2024.37135.0
Neurological complications in patients after COVID-19
Sousa, G. H. M., & Melo, R. S. B. (2024) · Fisioterapia em Movimento · doi:10.1590/fm.2024.37135
Perspective Chapter: Respiratory Disorders and Brain Damage in Long COVID
Stamenova, E., Kostov, K., Калпачки, Р., Kalpachka, D., Gulev, E., & Kovachev, T. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1006968
Dynamics of Changes in the Level of Cognitive Functioning Among Patients After SARS-CoV-2 Infection ‒ A Proposal for Remote Neuropsychological Assessment in a Longitudinal Study
Malinowska, E., Żarnecka, D., & Łojek, E. (2024) · Przegląd Psychologiczny · doi:10.31648/przegldpsychologiczny.10467
References
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.09996-8
Pathogenic Factors Related to Mental and Neurological Disorders
Anisman, H., Hayley, S. P., & Kusnecov, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.00004-1
COVID-19 and Neurodegenerative Diseases: One Health Approach
Saxena, S. K., Ansari, S., Sharma, D., Maurya, V. K., & Kumar, S. (2024) · Sustainable development · doi:10.5772/intechopen.115538
ALTERACIONES COGNITIVAS Y FUNCIONALES ENCONTRADAS EN EL SÍNDROME POST-COVID-19 EN PERSONAS MAYORES: REVISIÓN INTEGRATIVA
Rodrigues, I. F. A., Silva, K. H. C. V. E., Stephanus, A. D., & de Carvalho, L. S. F. (2024) · Cogitare Enfermagem · doi:10.1590/ce.v29i0.96897
COGNITIVE AND FUNCTIONAL CHANGES FOUND IN POST-COVID-19 SYNDROME IN ELDERLY PEOPLE: INTEGRATIVE REVIEW
Rodrigues, I. F. A., Silva, K. H. C. V. E., Stephanus, A. D., & de Carvalho, L. S. F. (2024) · Cogitare Enfermagem · doi:10.1590/ce.v29i0.96896
Post-COVID-19 symptoms and the development of mental disorders in pharmacy students: a cross-sectional study
Dang, K. D., Tran, H. Y., Nguyen, T. M., Lai, P. H., Huynh, K. T., Nguyen, K. A., & Ly, K. D. (2024) · Cogent Psychology · doi:10.1080/23311908.2024.2445875
Neurofunctional Impacts of COVID-19: Memory Loss and Cognitive Decline and Treatment
Deb, A., Pathak, K., Das, J., Bhattacharjee, R., Saikia, R., Gogoi, S., Sahariah, J. J., & Ahmad, M. Z. (2024) · Coronaviruses · doi:10.2174/0126667975336646241216051258
Crossroads of Neurology and Virology: The Neurological Manifestations of COVID-19
Eskandar, K. (2024) · Ukrainian Neurosurgical Journal · doi:10.25305/unj.310374
Avaliação dos fatores de risco associados à condição pós-Covid-19
Belo, M. M. D. A., Lucena, D. C. P., dos Santos, M. L., Cunha, R. J. P., Pereira, G. H. F., & de Freitas, G. R. M. (2024) · Semina Ciências Biológicas e da Saúde · doi:10.5433/1679-0367.2024v45n2p183
Efeitos da pandemia na saúde mental de cuidadores de pacientes com demência: revisão de literatura
Rebelo, V. S. M., Abe, Y. A. M., Tietz, A. P. D. S. F., Barbosa, M. D. L., Chianezio, G. B., Júnior, E. F. D. N., Tolazzi, L. B., de Lira, M. P., Bergmann, T. R., do Nascimento, É. T. M. L., et al. (2025) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.18n.1-222
Long-term cognitive impairment, psychological disorders, and functional limitations in COVID-19 survivors: A 2-year follow-up at a tertiary care hospital in Bengaluru
Shivamadhu, S., Ram, V. A., Singh, H., Raj, M. P., & Thyagaraj, V. (2025) · Archives of Mental Health · doi:10.4103/amh.amh_168_24
Mood disorders after COVID-19 infection: a single-center experience
Üzer, F., Çilli, A., Öner, Ş., Emek, M., & Yalçın, A. N. (2024) · Malawi Medical Journal · doi:10.4314/mmj.v36i4.1
Acute and long-term neurological manifestations of Covid-19: insights from virology and neurology
Eskandar, K. (2025) · Headache Medicine/Revista Headache Medicine · doi:10.48208/headachemed.2025.2
Multitarget-based in silico screening from phytoactive compounds of Garcinia linii fighting toward severe acute respiratory syndrome coronavirus-2
Chen, T., Shen, Z.-H., Tsai, M., Weng, C., & Leong, M. K. (2025) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_226_24
Neurotoxic Implications of Human Coronaviruses in Neurodegenerative Diseases: A Perspective from Amyloid Aggregation
Nguyen, T. H. V., Ferrón, F., & Murakami, K. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00153
Cognitive Performance and Mental Health in Long COVID Patients: A Cross-Sectional Study
Bravo, R. G., Gebhardt, C. L., Infanti, A., Billieux, J., Ritzen, M., Moritz, S., Benoy, C., & Vögele, C. (2025) · Verhaltenstherapie · doi:10.1159/000547365
Cognitive Impairment in Asthenic Disorders
Chutko, L. S., Surushkina, S. Y., Yakovenko, E. A., Scheglova, L. V., & Мирзаева, Л. М. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01861-5
Using machine learning to identify risk factors for Alzheimer's disease among older adults in the United States: The role of chronic and behavioral health
Ahmmad, M. R., Hossain, M. E., Khan, M. T. F., & Paudel, S. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251377691
Markers of inflammation and angiogenesis in patients with ischemic stroke after the new coronavirus infection
Butaeva, K. V., Voskresenskaya, O. N., Абусуевна, А. Б., & Захарова, Н. Б. (2025) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2025125101100
Trajectories of symptoms in the acute phase of COVID-19 infection and their association with anxiety and depression 2 years after infection
Wen, J., Zhang, L., Yuan, L., Li, K., Tang, Z., Zhang, Z., & Yan, Y. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07655-w
Additional file 2 of A brain cytokine-independent switch in cortical activity marks the onset of sickness behavior triggered by acute peripheral inflammation
Kurki, S., Ala‐Kurikka, T., Lipponen, A., Pospelov, A. S., Rõlova, T., Koıstınaho, J., Voipio, J., & Kaila, K. (2024) · Figshare · doi:10.6084/m9.figshare.26607115
Additional file 2 of Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Leitzke, M. (2024) · Figshare · doi:10.6084/m9.figshare.26560283
Additional file 4 of Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Leitzke, M. (2024) · Figshare · doi:10.6084/m9.figshare.26560289
Additional file 1 of Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Leitzke, M. (2024) · Figshare · doi:10.6084/m9.figshare.26560280
Additional file 3 of Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Leitzke, M. (2024) · Figshare · doi:10.6084/m9.figshare.26560286
Additional file 1 of Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study
Romero-Duarte, Á., Rivera-Izquierdo, M., de Alba, I. G.-F., Pérez-Contreras, M., Fernández‐Martínez, N. F., Ruiz-Montero, R., Serrano-Ortiz, Á., Ortiz-González-Serna, R., Salcedo-Leal, I., Jiménez-Mejías, E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14623436
Additional file 1 of Impact of Covid-19 in pregnancy on mother’s psychological status and infant’s neurobehavioral development: a longitudinal cohort study in China
Wang, Y., Chen, L., Wu, T., Shi, H., Li, Q., Jiang, H., Zheng, D., Wang, X., Wei, Y., Zhao, Y., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13185897
Additional file 1 of A brain cytokine-independent switch in cortical activity marks the onset of sickness behavior triggered by acute peripheral inflammation
Kurki, S., Ala‐Kurikka, T., Lipponen, A., Pospelov, A. S., Rõlova, T., Koıstınaho, J., Voipio, J., & Kaila, K. (2024) · Figshare · doi:10.6084/m9.figshare.26607112
Additional file 2 of Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study
Romero-Duarte, Á., Rivera-Izquierdo, M., de Alba, I. G.-F., Pérez-Contreras, M., Fernández‐Martínez, N. F., Ruiz-Montero, R., Serrano-Ortiz, Á., Ortiz-González-Serna, R., Salcedo-Leal, I., Jiménez-Mejías, E., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14623439
Post-COVID Cognitive Impairment in Older Adults: Implications of Symptom Severity and Cardiovascular Comorbidities
Amini, R., Udoh, I. I., & Patel, J. (2025) · Journal of Applied Gerontology · doi:10.1177/07334648251409916
Single-cell alternative polyadenylation analysis reveals mechanistic insights of COVID-19-associated neurological and psychiatric effects
Chen, Q., Gu, Y., Liu, S., Li, X., Xu, R., Ye, R., Yang, J., & Ning, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0324689
Gender differences in the post-COVID course (a literature review)
Andreeva, I. Y., & Khritinin, D. F. (2025) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2512-07
A Call for Services: Building the System PCNS Patients Deserve
Nandasiri, S., & Wijeratne, T. (2026) · Springer eBooks · doi:10.1007/978-3-032-14995-4_6
Unveiling the Intricacies of Implicit Motor Learning in Adults Recovered from COVID-19
Oparina, E., Antonio, D. S., Russo, G., Vieira, E. R., & Bigliassi, M. (2026) · Journal of Motor Behavior · doi:10.1080/00222895.2026.2637940
Is Alzheimer’s an Autoimmune Disease?
Corrada, B. R., & Speth, R. C. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05790-3
COVID-19 and neurodegeneration: Perspectives on the impact of viruses on the brain
Luna-Tenorio, E., Torres-Mendoza, J. N., Franco-Colín, M., Álvarez‐González, I., de la Cruz‐López, F., Garcés‐Ramírez, L., & Luna‐Muñoz, J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261434258
Reduced cortical brain perfusion following COVID-19 infection: impact of COVID-19 severity and relation to memory performance
Palmer, J. M., Matijevic, S., Ugonna, C., Galdamez-Avila, A., Rhodes, A., Chen, N.-K., Arias, J. C., Patterson, D. K., Wang, D. J. J., & Ryan, L. (2026) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2026.1575787
Plasma Membrane Redox Failure Links COVID-19 Metabolic Stress to Ferroptotic Neurodegeneration
Lee, J., Hwang, H., & Hyun, D. (2026) · Antioxidants · doi:10.3390/antiox15050572 · Cited by 1
Exploring Prolonged Grief Experiences of Ethnoracial Minoritized Caregivers: An Emic Perspective
Dsouza, V. F., Reardon, B., & Giscombé, C. L. W. (2026) · Research in Nursing & Health · doi:10.1002/nur.70092
Optimal doses of cognitive digital therapeutics for pediatric patients with cognitive impairments: A retrospective study based on big data
Liu, Y., Liang, S., Liang, A., Guo, Y., Ma, X., Li, Q., Wang, R., Zhao, X., Wang, S., Chu, P., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-05080-8
Involvement of NLRP3 Inflammasome in Methamphetamine Augmentation of SARS-CoV-2 N-Protein-Induced Neuroinflammation in Rat Microglial Cells
Dutta, D., Liu, J., & Xiong, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156960
β-Cell Dysfunction in COVID-19 and Post-COVID Syndrome: Molecular Mechanisms Linking Inflammation, Oxidative Stress, and Insulin Secretion
Tsvetkova, V. V., & Todorova, K. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167083
Identifying EEG biomarkers of fatigue and brain fog in long COVID: insights from rest and movement-related brain activity
Sánchez, M. C., Fajardo, K. M., Long, S., Janaudis‐Ferreira, T., Duclos, C., & Boudrias, M. (2026) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2026.112230
Immune stress and anxiety in Alzheimer’s disease: Neurobiological intersections and pathophysiological implications
Rasool, I., Bashir, D. J., Mehmood, R., Ahmad, M., Faheem, M. M., Malik, A., & Bhat, K. A. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.08.025
Стратификация факторов риска постковидных осложнений ЖКТ. Профилактика и лечение
Kaleda, S., & Mirzakarimova, F. (2024) · Eurasian Journal of Medical and Natural Sciences · doi:10.70413/ejmns-v04-i04-s10230

Authors: Heneka, M. T., Golenbock, D., Latz, E., Morgan, D., & Brown, R.
Affiliations: University of Bonn (DE)
German Center for Neurodegenerative Diseases (DE)
University of Massachusetts Chan Medical School (US)
Corresponding author: Heneka, Michael T.
ORCID: Heneka, Michael T.
Golenbock, Douglas
Latz, Eicke
Brown, Robert
Venue: Alzheimer's Research & Therapy
Publisher: Springer Science and Business Media LLC
Published: 2020-06-04
Volume: 12
Issue: 1
Pages: 69-69
ISSN: 1758-9193 (ISSN-L)
DOI: 10.1186/s13195-020-00640-3
PMC: PMC7271826
OpenAlex: W3032981909
Cited by: 555
References: 27
Citations by year: 2026: 18 · 2025: 36 · 2024: 74 · 2023: 72 · 2022: 165 · 2021: 137 · 2020: 52
FWCI: 46.12
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Alzheimer s Research & Therapy (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion, cc-by)
Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
DZNE Pub (submittedVersion, cc-by)
Funders: National Institutes of Health
National Institute on Aging (R01AG059752)
Topics: Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
Keywords: COVID-19 pandemic, SARS-CoV-2, neurological complications, cognitive decline, long-term effects, neuroinflammation, inflammatory cytokines, neurodegenerative diseases, post-COVID cognitive impairment, mechanical ventilation
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Animals, Brain, Humans, Pneumonia, Viral, Time Factors, Coronavirus Infections, Neurodegenerative Diseases, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Immediate and long-term consequences of COVID-19 infections for the development of neurological disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks